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Abstract
Background: Central nervous system (CNS) barriers play a pivotal role in the protection and homeostasis of the
CNS by enabling the exchange of metabolites while restricting the entry of xenobiotics, blood cells and
blood-borne macromolecules. While the blood–brain barrier and blood-cerebrospinal fluid barrier (CSF) control the
interface between the blood and CNS, the ependyma acts as a barrier between the CSF and parenchyma, and
regulates hydrocephalic pressure and metabolic toxicity. Neurocysticercosis (NCC) is an infection of the CNS caused
by the metacestode (larva) of Taenia solium and a major cause of acquired epilepsy worldwide. The common
clinical manifestations of NCC are seizures, hydrocephalus and symptoms due to increased intracranial pressure. The
majority of the associated pathogenesis is attributed to the immune response against the parasite. The properties
of the CNS barriers, including the ependyma, are affected during infection, resulting in disrupted homeostasis and
infiltration of leukocytes, which correlates with the pathology and disease symptoms of NCC patients.
Results: In order to characterize the role of the ependymal barrier in the immunopathogenesis of NCC, we isolated
ependymal cells using laser capture microdissection from mice infected or mock-infected with the closely related
parasite Mesocestoides corti, and analyzed the genes that were differentially expressed using microarray analysis. The
expression of 382 genes was altered. Immune response-related genes were verified by real-time RT-PCR. Ingenuity
Pathway Analysis (IPA) software was used to analyze the biological significance of the differentially expressed genes,
and revealed that genes known to participate in innate immune responses, antigen presentation and leukocyte
infiltration were affected along with the genes involved in carbohydrate, lipid and small molecule biochemistry.
Further, MHC class II molecules and chemokines, including CCL12, were found to be upregulated at the protein
level using immunofluorescence microcopy. This is important, because these molecules are members of the most
significant pathways by IPA analyses.
Conclusion: Thus, our study indicates that ependymal cells actively express immune mediators and likely
contribute to the observed immunopathogenesis during infection. Of particular interest is the major upregulation
of antigen presentation pathway-related genes and chemokines/cytokines. This could explain how the ependyma is
a prominent source of leukocyte infiltration into ventricles through the disrupted ependymal lining by way of pial
vessels present in the internal leptomeninges in murine NCC.
Introduction
There are different central nervous system (CNS) bar-
riers, which play a critical role in the homeostasis of the
CNS [1]. However, CNS infections lead to the dysfunc-
tion of these barriers. Compromised barrier properties
result in leakage of blood-born cells and molecules, as
well as a perturbed homeostasis of ions and macromole-
cules causing brain pathology [1]. Neurocysticercosis
(NCC) is a CNS infection caused by the metacestode
larva(e) form of the parasite Taenia solium and is char-
acterized by a range of pathological symptoms including
epileptic seizures, headaches and hydrocephalus [2]. Re-
cently, using a murine model for NCC, we have reported
that the distinct CNS barriers are differentially compro-
mised during parasite infection [2-5].
The CNS barriers include the blood–brain barrier (BBB)
comprised of pial and parenchymal vessels present in the
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leptomeninges and cortex, respectively, and the blood
cerebrospinal fluid barrier (BCB) present in the choroid
plexus [1,6]. The BBB and BCB prevent circulating blood
cells and macromolecules from getting into the CNS as
well as selectively regulating the exchange of metabolites
between blood and CSF. In addition to these barriers, the
lining of the ventricles known as the ependymal layer
functions as a third barrier separating the CSF from the
CNS tissue/parenchyma [7].
The ependymal barrier is composed of a single layer of
uniformly arranged ependymal cells or ependymocytes of
epithelial nature [1,7,8]. The barrier properties of ependyma
are evident from the presence of molecules known to con-
tribute to intercellular communication, paracellular sealing
and adherence of cells such as the gap junction molecule
connexin-43 [9,10], the tight junction molecules occludin
and ZO-1, and adherens junction molecules such as cad-
herins, α-catenin and β-catenin [3,11]. Ependymal barrier
function is further supported by the presence of enzymes
such as glutathione-S-transferase isoforms and monoamine
oxidase (MAO), which are known to participate in the me-
tabolism of neuroactive and vasoactive amines enabling the
ependyma to act as an amine-barrier system [12-15]. In
addition, the presence of electrolyte and water transporters
such as aquaporin family member 4 (AQP4) participates in
the maintenance of hydrocephalic pressure [16]. The epen-
dyma also appears to play a crucial role in the homeostasis
of the CNS by exchanging toxic metabolic byproducts and
water between the interstitial fluid of CNS cells and the
CSF in ventricles. However, despite the known, critical bar-
rier properties of the ependymal layer, the effect of infection
on ependymal cells has been largely understudied.
Previously, we have reported the presence and induction
of Toll-like receptors (TLRs) in the ependyma during mur-
ine NCC [17]. We have also described leukocyte infiltration
through the ependyma [3], indicating the compromised in-
tegrity of the ependymal barrier [3,5,17]. We hypothesize
that the ependyma can be an immunologically active site
that upon activation can produce immune effector mole-
cules that support leukocyte transmigration and the
dysfunction of the ependymal barrier. To test this hypoth-
esis, we isolated ependymal cells using Laser Capture
Microdissection (LCM) and applied a holistic approach of
microarray analyses to analyze potential infection-induced
changes in gene expression of the ependymal barrier.
Results from the transcriptome analyses of the ependyma
indicate that networks of genes related to the immune re-
sponse, cellular function and maintenance are affected,
which likely contribute to the neuropathology of NCC.
Materials and methods
Animals
Three- to 5-week-old female BALB/c mice were purchased
from the National Cancer Institute program (Bethesda,
MD). Experiments were conducted under the guidelines of
the IACUC, University of Texas System, the US Depart-
ment of Agriculture and the National Institutes of Health.
Parasites and infection
Parasite maintenance and intracranial infection were
performed using our protocol developed earlier [18].
M. corti metacestodes were maintained by serial intra-
peritoneal (i.p.) inoculation of 8- to 12-week-old female
BALB/c mice. For intracranial inoculations, parasites
were aseptically collected from the i.p. cavity of mice
that had been infected for about 4–6 months. Harvested
parasites were extensively washed in HBSS. Approxi-
mately 70 metacestodes were then suspended in 50 μl of
HBSS and injected intracranially into 3- to 5-week-old
female BALB/c mice using a 1-ml syringe and a 25-
gauge needle [18]. The needle was inserted to a 2-mm
depth at the junction of the superior sagittal and the
transverse sutures. This allows insertion of the needle
into a protective cuff avoiding penetration of the brain
tissue. Control mice were injected with 50 μl sterile
HBSS using the same protocol. Before intracranial in-
oculation, mice were anesthetized intramuscularly with a
50-μl mixture of ketamine HCL and xylazine (30 mg/ml
ketamine and 4 mg/ml xylazine).
Laser captured microdissection microscopy
Animals were killed 3 weeks after inoculation, which
was the peak of inflammation [18]. Before sacrifice, ani-
mals were anesthetized with 50 μl of a mixture of keta-
mine HCL and xylazine as above, and perfused through
the left ventricle with 15 ml of cold PBS. Perfused brains
were immediately removed, embedded in OCT resin
(Sakura, Torrance, CA) and snap frozen in 2-methyl bu-
tane (Fisher Scientific, Pittsburgh, PA) contained in
liquid nitrogen and stored at −80°C for later use. Then
10-μm-thick horizontal cryosections were serially cut
from each brain and placed on polyethylene naphtha-
late membrane slides (Leica Microsystems, Wetzlar,
Germany). The tissue sections were fixed in −20°C
acetone for 20 s and kept in dry ice followed by rapid
immunofluorescence staining. Briefly, tissues were sub-
jected to 70% ethanol at −20°C for 3 min and washed
with PBS. Sections were incubated with rabbit anti-
mouse β catenin (Zymed, San Francisco, CA) primary
antibody for 5 min followed by three washes for 1 min
each. Rhodamine Red-X (RRX)-conjugated goat anti-
rabbit secondary antibody (Jackson ImmunoResearch,
West Grove, PA) was applied for 3 min to detect primary
antibody followed by three washes. RNasinW RNase In-
hibitor (Promega, Madison, WI) and DEPC water were
used as required to ensure an RNase-free procedure.
Then, sections were serially dehydrated in 70% (10 s), 95%
(20 s), 100% (3× for 30 s each) and Shandon Histosolve™
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Xylene Substitute, an isoalkene hydrocarbon-based solu-
tion (Shandon, Pittsburgh, PA) 2× for 2 min each. Dehy-
drated sections were kept under desiccation until use for
LCM. Three animals per group (mock infection and M.
corti infection) were used to isolate ependymal cells.
LCM was performed with a Leica LMD 7000 micro sys-
tems (Leica Microsystems, Wetzlar Germany).
RNA isolation and linear amplification
From LCM-isolated ependymal cells, RNA was extracted
with the Pico PureTM RNA isolation kit (Arcturus Bio-
science, Mountain View, CA) according to manufacturer’s
protocol. DNase (Qiagen, Valencia, CA) treatment was per-
formed directly within the purification column to remove
any possible genomic contamination during the RNA ex-
traction process. The quality of the RNA was inspected
with the Agilent 2100 Bioanalzyer and NanoDrop ND-
1000. Samples passing quality control assessment were then
subjected to linear amplification and subsequently labeled
with the NuGEN Ovation Aminoallyl RNA Amplification
and Labeling System (NuGEN Technologies, San Carlos,
CA) as per manufacturer’s instructions.
Microarray and data processing
Arrays were printed at the Duke Microarray Facility using
the Genomics Solutions OmniGrid 100 Arrayer and
mouse genome oligo set (version 4.0). The Mus musculus
Operon v4.0 spotted microarray contains 35,852 longmer
probes representing 25,000 genes and about 38,000 gene
transcripts (Operon Biotechnologies, Huntsville, AL). The
amplified and labeled product was hybridized to Mus
musculus Operon v4.0 spotted microarray according to
the manufacturer’s protocol at 42°C with the MAUI
hybridization system (BioMicro Systems, MAUI hybrid-
ization System, Salt Lake City, UT). The array was then
washed at increasing stringencies and scanned on a Gene-
Pix 4000B microarray scanner (Axon Instruments, Foster
City, CA). Data processing and statistical analysis with the
software Genespring 7.3 (Agilent Technologies, Redwood
City, CA) were used to perform data analysis. Intensity-
dependent (Lowess) normalization was done on the entire
data set. To assess the quality of the data set, a principle
component analysis was performed on samples on expres-
sion of all genes with mean centering and scaling. Data
sets were filtered based on values, and probe sets with
background-subtracted intensity of 44 or less were ex-
cluded from the analysis. Based on replicates of each con-
dition, pair-wise comparisons were performed on data set
samples from mock-infected vs. infected samples. Differ-
entially expressed probe sets were selected based on a vol-
cano plot with a two-fold change and a p-value cutoff of
0.05. Differentially expressed genes were then clustered
using Average Linkage with Pearson correlation as the
similarity measurement. Molecular networks of the
selected molecules and specific pathways were analyzed
with Ingenuity Pathway Analysis (IPA) software (Agilent
Technologies).
Real-time RT-PCR analysis
RNA obtained from LCM-isolated ependymal cells was
subjected to linear amplification by the WT-Ovation™
Pico System (Nugen Technology). The resulting cDNA
was loaded onto Taq-Man Low Density Arrays micro-
fluidic cards, catalog number −4342259 (Applied Biosys-
tems, Carlsbad, CA) preloaded with fluorogenic probes
and custom-designed primers for genes of interest and
the housekeeping genes β-actin, ribosomal 18 S and
GAPDH (glyceraldehyde 3-phosphate dehydrogenase)
[19]. In some experiments, the commercially available
Mouse Immune Array, catalog number 4367786 (Ap-
plied Biosystems) was used. The plates were then loaded
on an ABI Prism 7900 HT Sequence Detection System
(Applied Biosystems). The target expression levels were
normalized to levels of the housekeeping genes 18 S, β-
actin and GAPDH in the same sample. In addition, real-
time RT-PCR to assess the relative expression of CCL12
and CCL7 chemokines in infected samples over mock-
infected samples was performed using Sybr Green (Ap-
plied Biosystems, CA). Primers for CCL12, CCL7 and
18 S were generated using Primer Express software (Ap-
plied Biosystems) as follows: 18 S, forward: CGG-CTA-
CCA-CAT-CCA-AGG-AA, reverse: GCT-GGA-ATT-A
CC-GCG-GCT; CCL-12, forward: TGC-CTC-CTG-C
TC-ATA-GCT-ACC, reverse: ACT-GGC-TGC-TTG-
TGA-TTC-TCC; CCL7, forward: GGA-TCT-CTG-CCA-
CGC-TTC-TG, reverse: GGC-CCA-CAC-TTG-GAT-
GCT. Expression of each specific gene in infected samples
over mock was calculated by the 2-ΔΔCt method, and
results are represented as ΔΔCt over mock [20].
Tissue preparation and immunofluorescence microscopy
Tissue preparation and immunofluorescence (IF) stain-
ing were performed using our protocol as described pre-
viously [21]. Mock-infected and infected brains were
harvested as described above. Perfused brains were im-
mediately removed, embedded in OCT resin (Sakura,
Torrance, CA) and stored at −80°C. Serial horizontal 10-
μm-thick cryosections were placed on Silane-prep slides
(Sigma-Aldrich, St. Louis, MO). The slides were air dried
overnight and fixed in fresh acetone for 20 s at RT.
Acetone-fixed sections were wrapped in aluminum foil
and stored at −80°C or processed immediately for IF
staining. Briefly, tissues were fixed in −20°C acetone for
10 min and then hydrated in PBS. Non-specific im-
munoglobulin binding was blocked by 30-min incuba-
tion at RT with 10% serum from the same species that
the fluorochrome-conjugated antibodies were derived.
Sections were incubated for 40 min with primary
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antibodies diluted in 3% species-specific serum. Sections
were washed 7× for 3 min each after incubation with the
specified antibodies. Secondary antibodies were incu-
bated for 30 min at RT when necessary. Then, sections
were mounted using Fluorsave reagent (Calbiochem, La
Jolla, CA) containing 0.3 μM 4′,6′-diamidino-2-pheny-
lindole dilactate (DAPI; Molecular Probes, Eugene, OR).
Negative controls using secondary antibodies alone were
included in each experiment and found to be negative
for staining. Fluorescence was visualized in a Leica
microscope (Leica Microsystems, Wetzlar Germany).
Images were acquired and processed using IP lab soft-
ware and Adobe Photoshop CS2 (Adobe, Mountain
View, CA). The primary antibodies against CCL12 (cata-
log n–o. BAF428) and CCL5 (catalog no. AF478) were
bought from R&D systems (Minneapolis, MN). Biotiny-
lated MHC II A/D antibody (catalog n–o. 553622) was
purchased from BD Pharmingen™ (San Diego, CA). Sec-
ondary antibody rabbit anti-goat conjugated with RRX
was obtained from Jackson ImmunoResearch (West




LCM was used to select and isolate ependymal cells
from mock or parasite-infected mice. A 3-week p.i. time
point was used as this is consistently the peak of
leukocyte infiltration [3]. In order to do LCM, brain sec-
tions were harvested on membrane slides and rapidly la-
beled for β-catenin by an optimized IF technique for
quick labeling of the ependyma followed by dehydration
with a xylene substitute as described in Materials and
Methods. This causes the ependymal layer to dissociate
from closely associated brain parenchyma, thus avoiding
unwanted contamination from glial cells (Figure 1). In
addition, ependymal cells that line the ventricles can be
easily distinguished from the epithelial cells of the chor-
oid plexus (also expressing β-catenin) by anatomical
structure and location.
Figure 1 Immunofluorescence labeling of ependymal cells.
(A) Immunofluorescence labeling of cryostat sections from snap
frozen brain tissue for ependymal cells (e) using anti- β catenin
antibody followed by serial dehydration (B). Same section after
subjected to LCM-mediated ependymal cells isolation.
Figure 2 Differentially expressed probe set in ependymal cells. Hierarchical cluster analysis of the differentially expressed probe sets by two
or more fold; 563 probe sets were significantly affected, (red=upregulated, green=downregulated). Mock A, B and C represent individual
biological samples from infected animals (n= 3). Three-week p.i. A, B and C represent individual biological samples from M. corti-infected mice
(n= 3).
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Assessment of differentially expressed genes in the
ependyma resulting from infection
To characterize differentially expressed genes, total RNA
was isolated from LCM-isolated ependymal cells and
subjected to linear amplification. The resulting cDNA
was subjected to microarray hybridization on Operon
chips containing probe sets representing the mouse gen-
ome. Data were processed by Genespring 7.3 software as
described in Materials and Methods. A total of 563
probe sets were found to be differentially expressed with
more than a two-fold change between mock and infected
samples. Using Average Linkage with Pearson correl-
ation as the similarity measurement of gene expression,
differentially expressed probe sets were clustered as
shown in Figure 2.
Operon chips represent the whole transcriptome
derived from the mouse genome depicting both well-
characterized genes and uncharacterized genes (Expres-
sion Sequence Tags). To identify the genes represented
by differentially expressed probe sets, the data generated
by Genespring were uploaded into Ingenuity Pathway
Analysis software (IPA). Out of 563 probe sets, 400
probes were found annotated and represent 382 genes.
Among 382 genes identified based on the common an-
notation “Ref. Seq,” 301 were upregulated and 81 were
downregulated.
The most upregulated genes include ARG1, CD74
(MHC class II invariant chain peptide), CCL8, serum
amyloid protein, PSMB9 (proteasomal degradation path-
way), SRGN [22], MHC class I and class II haplotype
Table 1 List of the most up- and downregulated (−) genes in ependymal cells from M. corti-infected brain in
comparison to mock-infected brain samples
Molecules Fold change Molecular function Biological process
ARG1 142.1 Arginase activity Arginine and proline metabolism; urea
cycle and metabolism of amino groups
CD74 126.8 MHC class II protein binding Antigen processing and presentation of
exogenous peptide antigen via MHC class II
CCL8 83.18 Chemokine activity; heparin binding Cell-cell signaling; chemotaxis
SAA1 77.66 G-protein coupled receptor binding Acute-phase response; chemotaxis
PSMB9 74.76 Peptidase activity Antigen processing and presentation;
aprotein polyubiquitination
HLA-C 53.43 Beta-2-microglobulin binding;
MHC class I receptor activity
Antigen processing and presentation of
peptide antigen via MHC class I
SRGN 53.19 Collagen binding; protein binding Apoptotic process; biomineral tissue
development; blood coagulation;
maintenance of granzyme B location in T
cell secretory granule
HLA-E 39.98 MHC class I receptor activity Antigen processing and presentation of
peptide antigen via MHC class I
HLA-B 36.35 MHC class I receptor activity Antigen processing and presentation of
peptide antigen via MHC class I
C3AR1 33.81 Complement component C3a
receptor activity; G-protein
coupled receptor activity;
Chemotaxis; complement receptor-mediated signaling pathway
ST18 −23.92 DNA binding Regulation of transcription
ONECUT2 −20.08 Sequence-specific DNA
binding transcription factor activity
Cell fate commitment; cilium assembly;
epithelial cell development
CEP76 −17.01 Protein binding Regulation of centriole replication
TNNT3 −11.99 Actin binding; calcium-
dependent ATPase activity
Muscle contraction; muscle filament
sliding; regulation of ATPase activity
AZI2 −6.99 TBK1/IKKi-binding I-kappaB kinase/NF-kappaB cascade
METTL2B −6.85 Methyltransferase activity;
transferase activity
Methylation
PCF11 −6.8 RNA 3'-end processing Termination of RNA polymerase II transcription
C20ORF24 −6.67 ND ND
ACBD3 −6.37 Fatty-acyl-CoA binding Lipid biosynthetic process; steroid biosynthetic process; transport
SFRS8 −5.65 RNA binding Negative regulation of nuclear mRNA splicing, regulation of transcription
ND, not determined.
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genes, and complement 3 receptor 1 gene, all of which
indicate upregulation of immune response genes
(Table 1). However, there was no change in the expres-
sion of lymphoid markers such as CD4, CD8 and CD19,
as well as myeloid cell markers such as CD11b, CD11c
and Ly6G between mock-infected and infected mice,
suggesting the expression of immune-related genes by
ependymal cells. Table 1 also provides the most downre-
gulated genes such as ST18 [23], oncut2 [24,25], ACBD3
[26] and CEP76 [27] encoding for molecules known to
participate in cell growth, differentiation and prolifera-
tion. A complete list of genes is shown in additional file
1: Table S1.
Biofunctions and networks of differentially expressed
genes
To determine the biofunctions associated with infection-
induced changes in gene expression, affected gene sets
were analyzed using IPA software. IPA uses the know-
ledge base created from previous findings regarding par-
ticular genes and associated functions. During analysis,
IPA finds the assigned function for given genes and fur-
ther categorizes genes with related biological functions
into biofunction classes. The top three affected classes
for the ependyma were disease and disorder, molecular
and cellular function, and physiological system develop-
ment and function (Table 2). The most significant func-
tions (p value, 9.03E-19 to 9.66E-04) within the disease
and disorder class were inflammatory response, im-
munological disease and inflammatory disease. In the
molecular and cellular functions class, the most signifi-
cant functions altered by infection were cellular develop-
ment, cellular movement, and cellular growth and
proliferation (p value, 4.49E-14 to 1.61E-03). The most
significant functions (p value, 1.29E-11 to 1.45E-03)
affected in the physiological system, development and
function class were hematological system development
and function, immune cell trafficking and tissue morph-
ology (Table 2).
To better understand the significance of the differen-
tially expressed genes in relation to each other, we ana-
lyzed the biomarkers for networks of genes. Networks
are generated based on a random selection of focus
genes with maximum connectivity, and several intercon-
nected focus genes are put together as a network in
order of high to low scores. The score is calculated
through Fisher’s exact test, which represents the ratio
between the number of all genes in a given network and
the number of focus genes. Based on the focus genes dif-
ferentially expressed during infection, several networks
were identified. Twenty-one networks out of 25 net-
works yielded a score of more than 3 (Additional file 2:
Table S2). The top gene networks included ‘antigen pres-
entation, inflammatory response, immunological disease;’
‘small molecule biochemistry, carbohydrate metabolism,
molecular transport;’ and ‘antimicrobial response, in-
flammatory response, cell-to-cell signaling and inter-
action” (Additional file 2: Table S2, Figure 3).
Genes mentioned in bold red color represent upregu-
lated genes, and genes in bold green color represent
Table 2 Top biological functions associated with genes differentially expressed in ependymal cells from NCC brain
Name p-value No. molecules
Diseases and disorders
Inflammatory response 9.03E-19 - 1.61E-03 109
Immunological disease 2.87E-13 - 1.37E-03 111
Inflammatory disease 1.25E-11 - 9.66E-04 127
Respiratory disease 1.84E-11 - 9.10E-04 51
Connective tissue disorders 2.15E-10 - 7.88E-04 90
Molecular and cellular functions
Cellular development 4.49E-14 - 1.61E-03 97
Cellular movement 5.98E-12 - 1.32E-03 79
Cellular growth and proliferation 2.37E-11 - 1.61E-03 122
Cell-to-cell signaling and interaction 1.36E-10 - 1.61E-03 82
Cell death 2.87E-09 - 1.58E-03 113
Physiological system development and function
Hematological system development and function 1.29E-11 - 1.61E-03 102
Immune cell trafficking 1.29E-11 - 1.61E-03 73
Tissue morphology 9.56E-11 - 1.45E-03 53
Hematopoiesis 4.10E-10 - 1.56E-03 60
Cell-mediated immune response 3.05E-08 - 1.27E-03 47
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downregulated genes. Genes in black color are not affected
in the data set but are relevant to the networks. (Descrip-
tion and fold change associated with differentially affected
genes are described in Additional file 1: Table S1).
We further tested for ‘canonical pathways’ within the
affected gene networks based on the ratio of molecules
known to participate in a given pathway, which were
also differentially expressed as a result of infection. The
top pathways are shown in Additional file 3: Table S3
and Figure 4. The top affected canonical pathways high-
light gene cascades related to the immune response. Of
particular interest is the antigen presentation pathway
(Figure 4).
Gene expression analysis by real-time PCR using the
cDNA linearly amplified from LCM-isolated ependymal
cells from mock-infected and infected brain samples.
Results are expressed as a ΔΔCt over mock-infected con-
trol mice and compared with the microarray outcome
Verification of infection-induced changes in immune-
related gene expression in ependyma
To confirm the altered pattern of gene expression obtained
from the microarray analysis, Taqman RT-PCR was per-
formed with amplified cDNA from LCM-isolated epen-
dymal cell RNA for a number of genes (Table 3). Genes
were chosen based on the outcome of the network and
pathway analysis and with emphasis on the immune re-
sponse (Figure 3 and Additional file 3: Table S3). All of the
genes analyzed were confirmed to be significantly upregu-
lated by RT-PCR and included antigen presentation-related
genes β2 microglobulin, MHC II and transcription factor
STAT1. Among the chemokines, CCL2, CCL12, CXCL10
and CXCLl1 were upregulated and relevant for trafficking
of monocytes and T cells, two leukocyte subsets that are
known to traffic through the ependyma during NCC [3]. In
addition, CCL5 and CCL7 were shown to be upregulated
by RT-PCR (CCL5, 15.5 fold, SE 0.64; CCL7, 8.7 fold, SE
0.74).
Protein expression of MHC class II and chemokine
expression by the ependyma
Network and pathway analyses showed an increased ex-
pression in the ependyma from infected mice of genes
responsible for antigen presentation in addition to sev-
eral chemokines. Brain sections from mock-infected and
3 week p.i. mice were analyzed by IF microscopy to de-
termine if protein expression was similarly increased
(Figure 5). In mock-infected samples, MHC II (I-A/I-E)
was not detected in the ependyma. However, there were
MHC II (I-A/I-E)-positive cells present in the choroid
plexuses, presumably circulating leukocytes (Figure 5A1).
In infected brains, MHC II (I-Ad/I-Ed) expression was
observed in ependyma present in the third and fourth
ventricles (Figure 5A2-4). Expression of the chemokines
CCL12 and CCL5 was undetected in the ependyma from
mock-infected animals (Figure 5B1, B5), but at a relatively
low basal level of expression in choroid plexuses as well as
astrocytic foot processes. After infection, CCL12 (Figure
B2-4) and CCL5 (Figure 5, B6) expression was induced in
the ependyma in comparison to mock-infected samples.
Interestingly, the localization of CCL12 and CCL5 was
mainly associated with the basolateral and apical surfaces.
Similar results were found for CCL7.
Discussion
Disruption of the barrier properties of CNS barriers cor-
relates highly with brain pathology [1,28]. In healthy
individuals the BBB is controlled in part by endothelial
cells that prevent blood cells and blood-borne molecules
from entering into the CNS as well as regulating ex-
change of metabolites. The BCB, which is comprised of
the choroid plexuses consisting of modified epithelial
cells surrounding fenestrated blood vessels, is a site of
CSF production and helps to regulate the exchange of
metabolites and provide immune surveillance [29]. Dur-
ing CNS infections, the BBB acts as a route for leukocyte
infiltration from blood to the subarachnoid space and
parenchyma, while the BCB has been described as a
route of leukocyte infiltration from blood to the CSF [6].
However, our prior studies demonstrate that during
murine NCC, another route for leukocyte infiltration
from blood to ventricles is through a disrupted epen-
dymal layer by way of subependymal pial vessels present
in the internal leptomeninges [2,3,5]. Such ependymal
disruption correlates with infection-induced increases in
MMP8, 3, 12, 2, 9 and 16 in addition to dislocated/rear-
ranged patterns of ependymal junction proteins includ-
ing occludin, cadherin, catenin α and β [2,3,5]. The
ependymal layer consists of specialized epithelial cells
Table 3 Verification of infection-induced gene expression
in the ependyma by real-time PCR
Gene symbol Ref. seq. Microarray RT-PCR
fold change ΔΔ Ct value SE p-value
ARG1 NM_007482 142.1 20.67 0.44 <0.001
MRC1 NM_008625 7.893 4.71 0.30 0.001
B2M NM_009735 19.11 4.49 0.45 <0.01
C3 NM_009778 14.46 4.50 0.26 <0.001
CCL2 NM_011333 3.205 14.10 0.65 <0.001
CCL12 NM_011331 18.84 7.58 0.82 <0.01
CXCL10 NM_021274 2.929 10.68 2.95 <0.05
CXCL11 NM_019494 21.73 10.13 1.60 <0.01
FN1 NM_010233 13.49 5.67 0.78 <0.01
STAT1 NM_009283 6.53 4.07 0.45 <0.01
H2-Ea NM_010381 16.41 10.54 1.20 <0.01
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that separate the parenchyma and the CSF, and regulate
hydrocephalic pressure and metabolic toxicity [7,8]. Of
the few studies of the ependyma, most have focused on
the transporters or physiological functions of ependyma
[30]. Recently, our laboratory and others have shown
disease-related induction in ependymal cells of TLR2, 4,
6 and 7 [17,31,32] as well as IL1R [33] and IL18 [34],
suggesting that the ependyma contributes to the
inflammatory process. It is particularly relevant for NCC
since in many clinical cases, as well as in the murine
NCC model, parasites can be lodged in ventricles, pro-
viding direct access of antigen/PAMPs to ependymal
cells [2,35]. The aim of this study was to assess broad-
based changes as well as immune-related changes in
gene expression of ependymal cells, leading to compro-
mised barrier function and leukocyte infiltration as a
Figure 3 Schematic representation of the most significant networks predicted by IPA. (A) Shape and relation legends. (B) Antigen
presentation, inflammatory response, immunological disease. (C) Small molecule biochemistry, carbohydrate metabolism, molecular transport.
(D) Antimicrobial response, inflammatory response, cell-to-cell signaling interaction. Red shape represents upregulated, green shape represents
downregulated, and white boxes represent genes not present in the data sets but relevant to biological pathways and incorporated to generate
networks.
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result of parasite infection. To date, no comprehensive
study has been done with the ependyma, mainly because
of the difficulty in isolating ependymal cells.
With the advent of LCM, it is possible to isolate a homo-
geneous cell population from heterogeneous tissue and
monitor such changes. In brain, the ependyma lies between
the parenchyma and internal leptomeninges separated by a
basement membrane [3]. As mentioned above, optimized
dehydration with an isoalkene hydrocarbon-based solution
that acts as a substitute for xylene caused the ependymal
layer to dissociate from closely associated brain paren-
chyma and meninges, reducing contamination from other
cells (Figure 1). Further, genes highlighted in networks
involved in the metabolism and cellular growth as well as
in metabolic pathways have been described previously in
the ependyma, such as induced expression of IGF1 [8], VIP
[8], glucokinase [8], ferric-chelate reductase 1 molecules
[36] and adenosine deaminase [37]. In addition, several
transporters are affected during infection, which might pro-
vide insight into a perturbed homeostasis during NCC be-
cause of ependymal cell activation, for example, a reduced
expression of the aquaporin family member AQP11.
Studies using AQP11-deficient mice have shown an abnor-
mal swelling of epithelial cells in kidneys, leading to cyst
formation in proximal tubes and eventually renal failure
and death [38]. Similarly, expression of fatty acid-binding
protein FABP7, which binds to polyunsaturated fatty acid,
correlates with neuroepithelial cell differentiation [39] and
ATP1B1, which ensures a proper electrochemical gradient
across the plasma membrane, are reduced, among others.
In contrast, the expression of the transporter molecule
ATP-binding cassette family member, multiple drug resist-
ance protein 3 (ABCC3) is upregulated. ABCC3 is known
to be induced as a result of immune activation by the
oncostatin-mediated pathway (OSM) [40].
Broad classification of differentially expressed genes in
gene networks and related biofunctions indicates that
genes involved in antigen recognition, uptake, proces-
sing, presentation and immune effector functions are
induced. Metacestodes during NCC continuously secrete
antigens, particularly glycoconjugates, some of which act
as PAMPS [41-46]. The murine NCC model developed
in our laboratory using a closely related cestode also
shows a similar release pattern of antigenic
Figure 4 Schematic representation of the most significantly affected pathway: “Antigen presentation pathway.” (Red indicates
upregulated genes in the ependymal cells from infected brain in comparison to ependymal cells from mock-infected brain samples.).
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glycoconjugates. Immune responses vary depending
upon the location of metacestodes in the CNS. Metaces-
todes lodged in ventricles and subarachnoid spaces are
known to cause more inflammation, symptoms related
with hydrocephalic pressure and associated epileptic sei-
zures [2,35,47]. In a previous study, we showed that
parasite-derived antigens are detected in the ventricles and
ependymal layer using a monoclonal antibody against a
secreted M. corti antigen [3]. Possible recognition and
phagocytosis are apparent by the induction of pathways
such as Fc receptor-mediated phagocytosis and
complement.
One of the striking observations is the upregulation of
MHC class I and class II genes in ependyma at both the
gene expression and protein level. MHC II antigen ex-
pression has been detected in non-professional antigen-
presenting cells of other immune privileged sites such as
the conjunctival epithelium in trachoma [48]. In CNS
ventricles, choroid plexus epithelial cells have been
shown to have increased expression of MHC I and
MHC II antigens upon infection with Theiler’s murine
encephalomyelitis virus (TMEV) and spontaneous ca-
nine distemper virus encephalitis [49,50]. Further, upon
stimulation with IFNγ under in vitro conditions, choroid
plexus epithelial cells have been shown to express MHC
class II molecules and present antigen to T cells [50].
During murine NCC, we have observed the presence of
αβ-T cells at 3 weeks p.i. in ventricles [21]. It is possible
that antigen availability and the activation state of epen-
dyma influence the trafficking and/or expansion/skewing
of T cells in the ventricles. In addition, it might also help
in the retention of T cells in ventricles that have
migrated through the activated ependyma, as recent
reports suggest that antigen presentation upon egress
from the BBB helps T cells to stay in the CNS environ-
ment [51].
There are several potential mechanisms leading to
ependymal cell activation and MHC upregulation evi-
dent in the array data. One such gene, STAT1, was veri-
fied by RT-PCR [52], which has been shown to regulate
the antigen presentation pathway along with IRF1 [53].
Induction of transcription factors STAT1, IRF1, IRF5
and 7 also correlates with our previous finding in which
the ependyma was found to express high levels of TLR7
during infection [54] and is in agreement with the
study in which IFNγ administration in rats by intraven-
ous infusion led to induction of MHC class II in
various cells including the ependyma [55]. Other
reports have shown that IFNγ stimulation leads to in-
duction of MHC II in bronchial epithelial cells, and
upon engagement with bacterial superantigen, toxic
shock syndrome toxin 1 (TSST1) mediates TNFα and
IL8 gene expression [56-59].
Our data show that during infection, ependymal cell ac-
tivation leads to expression of chemokines. Chemokines
play a critical role in leukocyte infiltration. Chemokines
exert chemotaxis by binding to their respective receptor
that leads to downstream signaling events resulting in the
tight binding of leukocytes [29]. Our data show that che-
mokines CCL2, CCL5, CCL7, CCL8, CCL9, CCL6,
CCL12, CCL11, CCL13, CXCL10 and CXCL11 are upre-
gulated by infection at the transcript level. Our experi-
ments further indicate the protein localization pattern of
CCL12 and CCL5 in apical and baso-lateral surfaces of
ependymal cells. Among these chemokines, monocyte
chemoattractant protein (MCP) family members CCL2,
CCL8, CCL12 and CCL13 are known ligands for CCR2
expressed by monocytes [60]. Studies in the Experimental
Autoimmune Encephalitis (EAE) model using CCR2−/−
mice indicate that CCR2 plays a crucial role in recruit-
ment of monocytes, and these mice are resistant to EAE
[61]. Among the ligands for CCR2, CCL2 has been shown
to be non-redundant as mice lacking CCL2 display a simi-
lar clinical phenotype as the CCR2−/− mice during EAE
and are characterized by impaired monocyte recruitment
[61]. In addition, CXCL10 and CXCL11 chemokines are
recognized by chemokine receptor CXCR3, which is
expressed by activated T cells [62,63]. Blockade of
CXCL10 with neutralizing antibodies results in reduced
numbers of inflammatory T cells and decreased severity
of EAE. Similarly, neutralization of CXCR3 reduces
CD4+ T cell infiltration into the CNS upon intracranial
infection with the mouse hepatitis virus (MHV) and
mitigates demyelination [64]. CXCR3 has been thought
to play a role in retention of CD4+ T cells in CNS [62].
Expression of these chemokines by ependymal cells
likely attracts leukocytes expressing respective receptors
and enhances trafficking of leukocytes into the ventri-
cles originating from pial vessels in the internal
leptomeninges.
Taken together, our data suggest that gene expression
by ependymal cells is dramatically affected by parasite in-
fection in murine NCC. Although some contamination
by extravasating leukocytes present in the ependymal
(See figure on previous page.)
Figure 5 Schematic representation of the most significantly affected pathway: “Antigen presentation pathway. (a) MHC II expression in
the ependyma, A1. Mock (IF +DIC, 20×), A2. Infected (IF +DIC, 20×). Magnified images (63×) showing ependyma during NCC without DIC (A3)
and with DIC (A4). (b) Chemokine CCL12 (B1-B4) and CCL5 (B5-B6) expression in ependyma, B1. Mock (IF +DIC, 20×), B2. Infected (IF +DIC, 20×).
Magnified images showing CCL12 expression near parasite (B3) and cellular distribution of CCL12 (B4, 63×), CCL5 expression in mock (B5, IF, 40×)
and infected (B6, IF, 40×). (e= ependyma, CP= choroid plexus, P=parasite).
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layer cannot be ruled out, it appears to be minimal based
on no change in the expression of lymphoid markers
such as CD4, CD8 and CD19 as well as myeloid cell mar-
kers such as CD11b, CD11c and Ly6G between mock-
infected and infected mice. Importantly, the data indicate
that the ependyma becomes an immunologically active
site. Thus, it appears that the ependyma contributes to
the immunopathology associated with NCC and consist-
ent with the ventriculitis associated with this disease
[65,66].
Conclusion
This study provides the first comprehensive gene expres-
sion analysis of ependymal cells in a disease condition.
Our microarray results derived from ependymal cells es-
tablish the biomarkers affected in the ependyma barrier
during parasitic infection. Specific pathways indicate that
ependymal cells actively express immune mediators and
likely contribute to the observed immunopathogenesis
during NCC [65-70]. In addition, during CNS infections,
the BBB and BCB are described as the main routes of
leukocyte infiltration [6]. However, during murine NCC,
the ependyma is a prominent source of leukocyte infil-
tration into the ventricles (blood to the ventricle) [3]. To
this end, upregulation of antigen presentation pathway-
related genes and chemokines/cytokines are important
and provide insight into how ependymal cells could sup-
port leukocyte infiltration.
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